Marion L.
- Country
- France
- Department
- Service de maladies infectieuses et Tropicales
Research Overview
- Comparison of Rifabutin and Rifampicin in the Management of Staphylococcal Prosthetic Joint Infection Using DAIR Strategy: A Multicenter Randomized Non-Inferiority Trial
- Evaluation of Rifampicin Efficacy and Safety in Cutibacterium acnes Prosthetic Joint Infections with Amoxicillin, Moxifloxacin, Clindamycin, and Doxycycline
Data & Insights
Has run more than one trial at 8 of 39 partner sites.
Specializations
Prosthetic Joint Infections
The investigator specializes in the treatment of prosthetic joint infections, with particular focus on infections caused by Cutibacterium acnes and staphylococcal organisms.
- Bacterial Pathogens Treatment
- Joint Replacement Complications
- Antimicrobial Therapy
Their research encompasses both methicillin-susceptible and methicillin-resistant infections.
Antibiotic Therapeutics
The investigator focuses on optimizing antibiotic treatments, particularly studying the effectiveness of rifampicin and rifabutin in orthopedic infections.
- Antibiotic Safety Profiles
- Treatment Efficacy Assessment
- Comparative Drug Studies
Their work includes evaluation of various antibiotic treatment strategies for complex joint infections.
Surgical Management
The investigator studies surgical intervention approaches, particularly the DAIR strategy (Debridement, Antibiotics and Implant Retention) for infected joint prostheses.
- Surgical Intervention Protocols
- Implant Retention Techniques
- Post-Surgical Care
Their research integrates surgical and antimicrobial approaches in infection management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.